References
- Kochanek KD, Murphy SL, Xu JQ, Arias E. Deaths: final data for 2017. National Vital Statistics Reports; June 24, 2019;68(9).
- Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011–2016. Hyattsville, MD: National Vital Statistics Reports 2018.
- Overdose Death Rates. National Institute on Drug Abuse. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates [cited 2020 March]. Accessed May 22, 2020.
- Levine M, Sanko S, Eckstein M. Assessing the risk of prehospital administration of naloxone with subsequent refusal of care. Prehosp Emerg Care. 2016;20(5):566–9. doi:10.3109/10903127.2016.1142626.
- Vilke GM, Sloane C, Smith AM, Chan TC. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport. Acad Emerg Med. 2003;10(8):893–6. doi:10.1197/aemj.10.8.893.
- Vilke GM, Buchanan J, Dunford JV, Chan TC. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehosp Emerg Care. 1999;3(3):183–6. doi:10.1080/10903129908958933.
- Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehospital Emergency Care. 2011;15(3):320–4. doi:10.3109/10903127.2011.569854.
- Boyd JJ, Kuisma MJ, Alaspaa AO, Vuori E, Repo JV, Randell TT. Recurrent opioid toxicity after prehospital care of presumed heroin overdose patients. Acta Anaesthesiol Scand. 2006;50(10):1266–70. doi:10.1111/j.1399-6576.2006.01172.x.
- Weiner SG, Baker O, Bernson D, Schuur JD. One-year mortality of opioid overdose victims who received naloxone by emergency medical services. Ann Emerg Med. 2017;70(4):S158. doi:10.1016/j.annemergmed.2017.07.281.
- Ashburn NP, Ryder CW, Angi RM, Snavely AC, Nelson RD, Bozeman WP, McGinnis HD, Winslow JT, Stopyra JP. One-year mortality and associated factors in patients receiving out-of-hospital naloxone for presumed opioid overdose. Ann Emerg Med. 2020;75(5):559–67. doi:10.1016/j.annemergmed.2019.11.022.
- Wong L, Hawkins J, Langness S, Murrell K, Iris P, Sammann A. Where are all the patients? Addressing Covid-19 fear to encourage sick patients to seek emergency care. NEJM Catalyst. 2020. https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0193
- Centers for Disease Control and Prevention. National Syndromic Surveillance Program (NSSP): Emergency Department Visits Percentage of Visits for COVID-19-Like Illness (CLI) or Influenza-like Illness (ILI) September 29, 2019 – April 4, 2020 Data as of April 9, 2020. U.S. Department of Health and Human Services. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/04172020/covid-like-illness.html. Published 2020. Accessed.
- American College of Emergency Physicians. Morning Consult American College of Emergency Physicians COVID-19. April 2020.
- Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Zhu Y, Liang D, Huang D. High mortality among patients with opioid use disorder in a large healthcare system. J Addict Med. 2017;11(4):315–9.
- Becker WC, Fiellin DA. When epidemics collide: Coronavirus Disease 2019 (COVID-19) and the opioid crisis. Ann Intern Med. 2020;173(1):59–60. doi:10.7326/M20-1210.
- Khatri UG, Perrone J. Opioid use disorder and COVID-19: Crashing of the crises. J Addict Med. 2020;14(4):e6–e7. doi: 10.1097/ADM.0000000000000684.
- Dunlop A, Lokuge B, Masters D, Sequeira M, Saul P, Dunlop G, Ryan J, Hall M, Ezard N, Haber P, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J. 2020;17(1):26 doi:10.1186/s12954-020-00370-7.
- Centers for Disease Control and Prevention. CDC Confirms Possible Instance of Community Spread of COVID-19 in U.S. U.S. Department of Health and Human Services https://www.cdc.gov/media/releases/2020/s0226-Covid-19-spread.html. Published 2020. Accessed July 8, 2020.
- Ducey D. Declaration of Emergency COVID-19. 2020. https://azgovernor.gov/sites/default/files/declaraton_0.pdf
- Trump D. Proclamation on declaring a national emergency concerning the novel Coronavirus Disease (COVID-19) outbreak. https://www.whitehouse.gov/presidential-actions/proclamation-declaring-national-emergency-concerning-novel-coronavirus-disease-covid-19-outbreak/. Published 2020.
- Popescu A. How will we remember the pandemic? Museums are already deciding. The New York Times. https://www.nytimes.com/2020/05/25/arts/design/museums-covid-19-collecting.html. Published 2020. Accessed July 8, 2020.
- Hudnall D. Arizona's stay-at-home order is extended, and other takeaways from Ducey's Presser. Phoenix New Times. https://www.phoenixnewtimes.com/news/arizona-coronavirus-ducey-stay-at-home-extended-may-15-11467960. Published 2020.
- Fischer H. 'Cure is worse than the virus': Hundreds protest in Phoenix against pandemic closure orders. Capitol Media Services. https://tucson.com/news/local/cure-is-worse-than-the-virus-hundreds-protest-in-phoenix-against-pandemic-closure-orders/article_8ecdb515-993a-5c10-81fc-db7421699399.html. Published 2020.
- United States Census Bureau. Annual Estimates of the Resident Population for Incorporated Places of 50,000 or More, Ranked by July 1, 2019 Population: April 1, 2010 to July 1, 2019. U.S. Department of Commerce. https://www.census.gov/data/tables/time-series/demo/popest/2010s-total-cities-and-towns.html.
- Tucson C. Arizona Population: Census 2010 and 2000 Interactive Map, Demographics, Statistics, Quick Facts. Moonshadow Mobile, Inc. http://censusviewer.com/city/AZ/Tucson.
- Pima County Health Department. 2019 Quarterly Drug Overdose Fatality Report: 1/1/19-9/30/19. February 6, 2020.
- Hartnett KP, Kite-Powell A, DeVies J, Coletta MA, Boehmer TK, Adjemian J, Gundlapalli AV, National Syndromic Surveillance Program Community of Practice. Impact of the COVID-19 pandemic on Emergency Department Visits – United States, January 1, 2019-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(23):699–704. doi:10.15585/mmwr.mm6923e1.
- Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020;4(5):e10–e11. doi:10.1016/S2352-4642(20)30108-5.
- Samuels EA, D'Onofrio G, Huntley K, Levin S, Schuur JD, Bart G, Hawk K, Tai B, Campbell CI, Venkatesh AK. A quality framework for emergency department treatment of opioid use disorder. Ann Emerg Med. 2019;73(3):237–47. doi:10.1016/j.annemergmed.2018.08.439.
- Price T. Secretary price announces HHS strategy for fighting opioid crisis. U.S. Department of Health and Human Services. https://www.hhs.gov/about/leadership/secretary/speeches/2017-speeches/secretary-price-announces-hhs-strategy-for-fighting-opioid-crisis/index.html. Published 2017.
- Office of the Surgeon General. U.S. Surgeon General's Advisory on Naloxone and Opioid Overdose. U.S. Department of Health & Human Services https://www.hhs.gov/surgeongeneral/priorities/opioids-and-addiction/naloxone-advisory/index.html. Published 2018.
- World Health Organization. Community management of opioid overdose. https://www.who.int/publications/i/item/9789241548816. Published 2014.
- Berg S. Lifesaving naloxone should be available almost everywhere. American Medical Association. https://www.ama-assn.org/delivering-care/opioids/lifesaving-naloxone-should-be-available-almost-everywhere. Published 2019.
- National Association of Boards of Pharmacy. NABP issues policy statement supporting the pharmacist's role in increasing access to opioid overdose reversal drug. https://nabp.pharmacy/newsroom/news/nabp-issues-policy-statement-supporting-the-pharmacists-role-in-increasing-access-to-opioid-overdose-reversal-drug/. Published 2014.
- American Public Health Association. Reducing opioid overdose through education and naloxone distribution. https://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2014/07/16/13/08/reducing-opioid-overdose-through-education-and-naloxone-distribution.
- Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36(2):240–53. doi:10.1080/08897077.2015.1010032.
- Wagner KD, Valente TW, Casanova M, Partovi SM, Mendenhall BM, Hundley JH, Gonzalez M, Unger JB. Evaluation of an overdose prevention and response training programme for injection drug users in the skid row area of Los Angeles, CA. Int J Drug Policy. 2010;21(3):186–93. doi:10.1016/j.drugpo.2009.01.003.
- Behar E, Santos GM, Wheeler E, Rowe C, Coffin PO. Brief overdose education is sufficient for naloxone distribution to opioid users. Drug Alcohol Depend. 2015;148:209–12. doi:10.1016/j.drugalcdep.2014.12.009.
- Doe-Simkins M, Quinn E, Xuan Z, Sorensen-Alawad A, Hackman H, Ozonoff A, Walley AY. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health. 2014;14:297 doi:10.1186/1471-2458-14-297.
- Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174 doi:10.1136/bmj.f174.
- Albert S, Brason IIF, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011;12 Suppl 2:S77–S85. doi:10.1111/j.1526-4637.2011.01128.x.
- Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89–96. doi:10.1300/J069v25n03_11.
- Langham S, Wright A, Kenworthy J, Grieve R, Dunlop WCN. Cost-effectiveness of take-home naloxone for the prevention of overdose fatalities among heroin users in the United Kingdom. Value Health. 2018;21(4):407–15. doi:10.1016/j.jval.2017.07.014.
- Infinger AE, Dowbiggin PL, Bouland AJ, Studnek JR. Deployment of an EMS-based community naloxone distribution program. In. Presented at the National Association of EMS Physicians Annual Meeting, San Diego, CA, 2020.
- North Carolina Division of Public Health Injury and Violence Prevention Branch. North Carolina Naloxone Distribution Toolkit. North Carolina Division of Public Health. https://www.injuryfreenc.ncdhhs.gov/DataSurveillance/NaloxoneDistributionToolkitFinalApproved-042219.pdf. Published 2019.
- Project FRIEND. https://www.projectfriend.org/.
- City of Pittsburgh Mayor’s Office. Pittsburgh EMS Takes the Lead on Naloxone Leave Behind Program Pittsburgh Mayor's Office. https://pittsburghpa.gov/press-releases/press-releases.html?id=1481#:∼:text=PITTSBURGH%2C%20PA%20(FEBRUARY%2013%2C,a%20naloxone%20leave%20behind%20program.&text=While%20naloxone%20is%20not%20treatment,and%20provide%20opportunities%20for%20recovery. Published 2018.
- Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105(5):844–59. doi:10.1111/j.1360-0443.2009.02888.x.
- Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235–48. doi:10.1093/ije/dyt243.
- Institute of Medicine. Preventing HIV infection among injecting drug users in high-risk countries: An assessment of the evidence. Washington, DC: The National Academies Press; 2007.
- World Health Organization. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. 2004.
- Huo DZ, Bailey SL, Ouellet LJ. Cessation of injection drug use and change in injection frequency: the Chicago Needle Exchange Evaluation Study. Addiction. 2006;101(11):1606–13. doi:10.1111/j.1360-0443.2006.01577.x.
- Center for Innovative Public Policies. Needle exchange programs: is Baltimore a bust?. 1995.
- Havelock CT. North Carolina Launches First-Ever Syringe Exchange Through Fire and EMS. The Huffington Post. https://www.huffpost.com/entry/havelock-north-carolina-launches-first-ever-syringe_b_5a329162e4b06a512dd69e20. Published 2017. Accessed.
- Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550 doi:10.1136/bmj.j1550.
- Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011; August (8):CD004145. doi:10.1002/14651858.CD004145.pub4.
- D’Onofrio G, O’Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–44. doi:10.1001/jama.2015.3474.
- Bruneau J, Ahamad K, Goyer ME, Poulin G, Selby P, Fischer B, Wild TC, Wood E, CIHR Canadian Research Initiative in Substance Misuse. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247–E257. doi:10.1503/cmaj.170958.
- American Academy of Emergency Medicine. Management of Opioid Use Disorder in the Emergency Department: A White Paper Prepared for the American Academy of Emergency Medicine. 2019.
- Carroll G, Shah A, Wasserman D, Wilson BR, Hong R. Pre-hospital treatment of acute withdrawal with buprenorphine following naloxone administration for opioid overdose: A case series. In. Presented at the National Association of EMS Physicians Annual Meeting. San Diego, CA, 2020.
- Mechem CC, Yates CA, Rush MS, Alleyne A, Singleton HJ, Boyle TL. Deployment of alternative response units in a high-volume, urban EMS system. Prehosp Emerg Care. 2020;24(3):378–84. doi:10.1080/10903127.2019.1657212.
- SAMHSA. FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency, 2020.
- Drug Enforcement Administration. Use of telephone evaluations to initiate buprenorphine prescribing. U.S. Department of Justice. https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-022)(DEA068)%20DEA%20SAMHSA%20buprenorphine%20telemedicine%20%20(Final)%20+Esign.pdf. Published 2020. Accessed.
- Grover JM, Alabdrabalnabi T, Patel MD, Bachman MW, Platts-Mills TF, Cabanas JG, Williams JG. Measuring a crisis: Questioning the use of naloxone administrations as a marker for opioid overdoses in a large U.S. EMS System. Prehosp Emerg Care. 2018;22(3):281–9. doi:10.1080/10903127.2017.1387628.